PubRank

N Polentarutti

Author PubWeight™ 88.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997 4.19
2 Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992 4.11
3 Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000 4.07
4 Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993 3.62
5 Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 2000 3.06
6 Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994 2.63
7 Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J Immunol 2000 2.17
8 Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 1997 2.02
9 Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 1997 1.97
10 Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983 1.83
11 Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest 1985 1.79
12 Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J Leukoc Biol 2000 1.66
13 Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 1992 1.66
14 Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 1998 1.58
15 Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol 1992 1.51
16 IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology 1990 1.47
17 Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998 1.39
18 Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab Invest 2000 1.38
19 Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. J Immunol 1999 1.37
20 Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J Exp Med 1995 1.31
21 The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 1994 1.23
22 Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood 1994 1.17
23 Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor. Cancer Res 1977 1.14
24 Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemia. Eur J Haematol 1989 1.11
25 Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. J Immunol 1998 1.11
26 Toll-like receptor family and signalling pathway. Biochem Soc Trans 2000 1.11
27 Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors. Int J Cancer 1979 1.10
28 Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites. Clin Exp Immunol 1980 1.06
29 Expression of a heat-inducible gene of the HSP70 family in human myelomonocytic cells: regulation by bacterial products and cytokines. Blood 1991 1.02
30 MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression. J Leukoc Biol 1997 1.02
31 Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer 1983 0.99
32 Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors. J Natl Cancer Inst 1980 0.99
33 High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells. Oncogene 2007 0.97
34 A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur Cytokine Netw 1999 0.96
35 Differential expression of the common beta and specific alpha chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells. Exp Cell Res 1993 0.95
36 Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein-1 and related chemokines. J Leukoc Biol 1995 0.94
37 Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J Biol Chem 1994 0.93
38 Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin. Int J Cancer 1981 0.92
39 Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo. Cytokine 1998 0.92
40 Expression of c-jun protooncogene in human myelomonocytic cells. Blood 1989 0.91
41 Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram. J Neuroimmunol 2000 0.90
42 Expression of c-fos protooncogene in normal human peripheral blood granulocytes. J Exp Med 1987 0.89
43 Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts. J Immunol 1999 0.89
44 Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): a depot IL-1ra. Eur J Immunol 1999 0.88
45 Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice. J Natl Cancer Inst 1979 0.88
46 Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice. Int J Cancer 1980 0.88
47 Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells. Eur J Immunol 1994 0.88
48 Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages. Clin Exp Immunol 1980 0.87
49 Thrombin induces c-fos expression in cultured human endothelial cells by a Ca2(+)-dependent mechanism. Blood 1990 0.87
50 Interleukin-1 induces c-fos protooncogene expression in cultured human endothelial cells. Biochem Biophys Res Commun 1988 0.87
51 Heat shock induces the transcriptional activation of c-fos protooncogene. Biochem Biophys Res Commun 1990 0.87
52 Up-regulation of CCR2 chemokine receptor expression and increased susceptibility to the multitropic HIV strain 89.6 in monocytes exposed to glucocorticoid hormones. J Immunol 1999 0.87
53 Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor. Blood 1997 0.86
54 Effect of immunomodulators on effector cells involved in antibody-dependent cellular cytotoxicity: Brief communication. J Natl Cancer Inst 1977 0.85
55 Rapid killing of actinomycin D-treated tumor cells by mononuclear phagocytes: characterization of effector cells in mice. J Leukoc Biol 1986 0.84
56 Modulation of the locomotory capacity of human large granular lymphocytes. Cell Immunol 1986 0.84
57 Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: effects on cytotoxicity of tumor-associated macrophages and NK cells. Int J Cancer 1981 0.83
58 Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine. Cytokine 1996 0.83
59 Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex. Exp Nephrol 2000 0.82
60 Cytotoxicity of human peripheral blood monocytes against Trichomonas vaginalis. Clin Exp Immunol 1981 0.81
61 On thrombocytopenia developing in mice bearing a spontaneously metastasizing tumor. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1976 0.80
62 Activation of K cells in mice with transplanted tumours differing in immunogenicity and metastasizing capacity. Br J Cancer 1977 0.80
63 Rapid killing of actinomycin D-treated tumour cells by mononuclear phagocytes: reactivity in mouse strains with defective classical tumour cytotoxicity. Immunology 1986 0.79
64 Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors. Int J Cancer 1984 0.77
65 Selectivity release of the type II decoy IL-1 receptor. Cytokine 2000 0.77
66 Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1. Eur Cytokine Netw 1997 0.77
67 K cell activity in ovarian cancer patients given chemotherapy. Eur J Cancer 1979 0.77
68 Effects of disodium etidronate in murine tumor models. Eur J Cancer Clin Oncol 1984 0.76
69 Differential expression of Raf-1 protooncogene in resting and activated human leukocyte populations. Exp Cell Res 1991 0.76
70 Tumoricidal and immunoregulatory activity of macrophages from human ovarian carcinomas. Adv Exp Med Biol 1982 0.75
71 c-fos proto-oncogene expression in human NK/LGL cells: expression is not constitutive and is associated with functional activation. Int J Cancer 1988 0.75
72 The immunostimulatory activity of 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazole [3,2-alpha]-benzimidazole-2-acetic acid (NSC 208828). Eur J Cancer 1978 0.75
73 Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin. J Endocrinol Invest 2007 0.75
74 In vitro and in vivo cytotoxicity of possible uracil metabolites of methylxanthines. Toxicol Lett 1983 0.75
75 Increased expression of urokinase mRNA in bovine aortic endothelial cells treated with propranolol. Biochem Biophys Res Commun 1989 0.75
76 The macrophage content of tumors is unrelated to levels of NK cell-mediated resistance. J Leukoc Biol 1986 0.75
77 Effects of inactivated streptococci (OK-432) on macrophage functions in mice. J Immunopharmacol 1985 0.75
78 Evaluation of absorption with Limulus amebocyte lysate to remove contaminating endotoxin from interferon and lymphokine preparations. J Immunol Methods 1984 0.75
79 Combination chemo-immunotherapy with adriamycin in experimental tumor systems. Eur J Cancer 1977 0.75
80 Protooncogene expression in normal and tumor-infiltrating phagocytes. Immunol Lett 1987 0.75
81 c-Fos protooncogene expression in human normal peripheral blood leukocytes. Cytotechnology 1987 0.75
82 Defective chemotaxis of human alveolar macrophages. Clin Immunol Immunopathol 1988 0.75
83 c-fos and c-myc expression in human endothelial cells as a function of different culture conditions. Exp Cell Res 1990 0.75
84 Macrophage-mediated cytostatic activity on tumour cells after treatment with Triton WR 1339. Eur J Cancer 1978 0.75
85 Effects of a series of new synthetic high polymers on cancer metastases. J Med Chem 1973 0.75